Overview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa

Overview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa

The other diseases of the Millennium Development Goal 6

RELEASE DATE
19-Apr-2012
REGION
Africa
Research Code: M70B-01-00-00-00
SKU: HC01930-AF-MR_07036

$6,950.00

Special Price $5,212.50 save 25 %

In stock
SKU
HC01930-AF-MR_07036

$6,950.00

$5,212.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Research was carried out on the orphan disease and related drug space in Sub-Saharan Africa with emphasis on 5 countries, namely, Ghana, Nigeria, Uganda, Kenya and Tanzania. An analysis into the systems, treatment regimes and organisation and company involvement and their interrelations was carried out. Each country's status, with respect to these analyses results, was ascertained. Market dynamics, including challenges, drivers and restraints, were also identified along with potential involvement opportunities.

Table of Contents

Overview of The Orphan Diseases and Drugs Space in Sub-Saharan Africa

  • Introduction to The Orphan Drugs and Diseases Space in Sub-Saharan Africa

Overview of The Research Aims and Objectives

  • Introduction to the Research Aim and Objectives

Overview of The Research Scope, Definitions and Exchange Rates

  • Introduction to The Research Scope, Definitions and Exchange Rates

Overview of The Research Methodology

  • Introduction to The Research Methodology

Overview of Orphan Drugs and Diseases in Sub-Saharan Africa

  • An Introduction to Orphan Drugs and Diseases in Sub-Saharan Africa

Overview of Neglected Diseases in Sub-Saharan Africa

  • Introduction to the Neglected Diseases in Sub-Saharan Africa

Overview of Orphan Drugs and Their Disrtibution Programs

  • Introduction to Orphan Drugs and Their Distribution Programs

Overview of The Orphan Disease and Drug Space in Sub-Saharan Africa

  • Introduction to Frost & Sullivan
Related Research
Research was carried out on the orphan disease and related drug space in Sub-Saharan Africa with emphasis on 5 countries, namely, Ghana, Nigeria, Uganda, Kenya and Tanzania. An analysis into the systems, treatment regimes and organisation and company involvement and their interrelations was carried out. Each country's status, with respect to these analyses results, was ascertained. Market dynamics, including challenges, drivers and restraints, were also identified along with potential involvement opportunities.
More Information
No Index Yes
Podcast No
Author Megan Van Den Berg
Industries Healthcare
WIP Number M70B-01-00-00-00
Is Prebook No